Ass.-Prof. Dr. Florian Kopp
T: +43-1-4277-55581
1 - 10 out of 10
Janković ÐD, Šestić TL, Bekić SS, Savić MP, Ćelić AS, Scholda J et al. Development of new steroid-based hydrazide and (thio)semicarbazone compounds with anticancer properties. Journal of Steroid Biochemistry and Molecular Biology. 2024 Sep;242:106545. Epub 2024 May 16. doi: 10.1016/j.jsbmb.2024.106545



Decker S, Taschauer A, Geppl E, Pirhofer V, Schauer M, Pöschl S et al. Structure-based peptide ligand design for improved epidermal growth factor receptor targeted gene delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2022 Jul;176:211-221. doi: 10.1016/j.ejpb.2022.05.004




Kopp F. Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell. 2018 Jan;172(3):393-407. doi: 10.1016/j.cell.2018.01.011

Kopp F. An Argonaute phosphorylation cycle promotes microRNA-mediated silencing. Nature. 2017 Feb;542(7640):197-202. doi: 10.1038/nature21025

Kopp F. Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins. Cell. 2016 Jan;164(1-2):69-80. doi: 10.1016/j.cell.2015.12.017

1 - 10 out of 10

Rolle der nichtkodierenden RNA NORAD in Geweberegeneration

Kopp, F.

8/10/217/10/25

Project: Research funding


Department of Pharmaceutical Sciences

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2E449A

T: +43-1-4277-55581

florian.kopp@univie.ac.at